TD Cowen reiterates Buy rating on Oracle stock ahead of earnings

Published 08/09/2025, 15:04
TD Cowen reiterates Buy rating on Oracle stock ahead of earnings

Investing.com - TD Cowen has reiterated its Buy rating and $325.00 price target on Oracle (NYSE:ORCL) stock ahead of the company’s first-quarter earnings report scheduled for September 9. The company, currently valued at $668 billion, trades at a P/E ratio of 52.29, significantly above industry averages according to InvestingPro data.

The research firm expects Oracle to report 10% constant currency growth, up from 8% in the previous quarter, with continued strength in remaining performance obligations (RPO). TD Cowen’s checks indicate strong Oracle Cloud Infrastructure (OCI) demand from the company’s largest customers. This growth trajectory aligns with Oracle’s impressive 70.5% gross profit margin and robust revenue of $57.4 billion over the last twelve months.

The firm forecasts Cloud growth at 29% in the first quarter compared to 27% last quarter, projecting an increase to 40% for the full fiscal year 2026 as Stargate capacity becomes available. TD Cowen believes the OCI growth potential in fiscal year 2026 remains "under-appreciated and under-modeled" by the market.

Oracle shares have risen approximately 30% since the fourth-quarter earnings announcement and currently trade at about 23 times the calendar year 2027 estimated price-to-earnings ratio. The stock has gained momentum as multi-cloud deployments from the core customer base strengthen and Fusion migrations accelerate. InvestingPro data shows Oracle has delivered an impressive 65.9% return over the past year, though current valuations suggest the stock may be trading above its Fair Value.

TD Cowen expects the first-quarter results to drive Oracle shares higher as the company outlines a path toward its target of over $275 billion in RPO for fiscal year 2026, maintaining its price target based on approximately 32 times calendar year 2027 estimated P/E with over $10 in earnings per share. For deeper insights into Oracle’s valuation metrics and growth potential, access the comprehensive Pro Research Report available exclusively on InvestingPro, which includes detailed analysis of the company’s financial health and future prospects.

In other recent news, Oracle has been the focus of several significant developments. The company is set to receive a $38 billion debt package, led by JPMorgan Chase and Mitsubishi UFJ Financial Group, to fund data centers in Wisconsin and Texas. Meanwhile, NYC Health + Hospitals has announced the implementation of Oracle Fusion Cloud Applications to modernize its operations across finance, supply chain, and human resources. On the financial front, Morgan Stanley has raised Oracle’s stock price target to $246, maintaining an Equalweight rating, while Global Equities Research increased their target to $400, citing a shift towards Context Engineering as a positive trend for Oracle. Additionally, Citizens JMP reiterated a Market Outperform rating with a $315 price target, supported by positive industry feedback. These developments highlight Oracle’s strategic moves and positive market sentiment.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.